Friday 6 November 2026 Export MDLN’s income statement to Excel — free account

Medline Inc.

MDLN Healthcare Medical Instruments & Supplies

Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.

Revenue: +14.1%
Free cash flow: +916.1%
Total debt: −23.7%

Quarter to September 2026, against a year earlier

Insider buying

39.96 0.39 −0.97%

Follow MDLN

Alert me

Market cap: $52.3B
P/E: 58.4×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: 2.25
Beneish M: −2.38
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Medline Inc. (MDLN) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
Supply Chain Solutions	14,712	51.74%
Medline Brand	13,720	48.26%
Gross margin		26.44%
Operating margin		7.78%
Pre-tax margin		4.39%

Revenue by segment $m

Line	FY2025	FY2024	FY2023
Supply Chain Solutions	14,712 51.74%	12,992 50.94%	11,618 50.01%
Medline Brand	13,720 48.26%	12,515 49.06%	11,613 49.99%
Revenue	28,432	25,507	23,231

Revenue by region $m

Line	FY2025	FY2024	FY2023
United States	26,479 93.13%	23,747 93.10%	21,800 93.84%
International	1,953 6.87%	1,760 6.90%	1,431 6.16%
Revenue	28,432	25,507	23,231

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
Organic sales growth	Q3 FY2026	10.5%	—	—

	Q3 FY2026	Q2 FY2026	Q1 FY2026	Q4 FY2025
Organic sales growth	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡
	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.